自由エネルギーベースのタンパク質設計:移動型アプローチによる細胞レチノ酸結合タンパク質IIの再設計
Haizhen A Zhong1,2, Elizabeth M Santos1, Chrysoula Vasileiou1
1Department of Chemistry , Michigan State University , East Lansing , Michigan 48824 , United States.
Journal of the American Chemical Society
|February 27, 2018
まとめ
この研究は,タンパク質の変異が小分子結合にどのように影響するかを予測するための,迅速で知識に基づいた方法を紹介しています. このアプローチは,タンパク質の設計と薬物の発見に役立つ,結合の自由エネルギーを正確に推定します.
科学分野:
- コンピュータ化学
- タンパク質工学
- 分子モデリング
背景:
- タンパク質の設計には,タンパク質変異による小分子結合の微調整が不可欠です.
- 結合の自由エネルギーを計算するための既存の方法は,正確さと速度によって異なります.
研究 の 目的:
- タンパク質変異による結合自由エネルギーの変化を推定するための迅速で知識に基づいた計算方法を開発する.
- 小分子とタンパク質の相互作用に対する突然変異の影響を予測する精度と効率を向上させる.
主な方法:
- 絶対的および相対的結合自由エネルギーを推定するために,知識に基づく移動型 (MT) のアプローチが採用されました.
- この方法は,CRABPIIへのレチノ酸結合の変異遺伝データを用いて遡及的に検証された.
- 将来の予測は作られ,実験的に検証された.
主要な成果:
- MTベースのアプローチは,変異によって影響される結合自由エネルギーを正確に推定します.
- CRABPIIの変異遺伝子のデータを用いた遡及的検証は,強力な性能を示した.
- 将来の予測は実験的に確認され,高親密性の変異体が特定されました.
結論:
- 開発されたMTベースの方法は,小分子結合親和性に対する突然変異の影響を迅速かつ正確に予測するための方法です.
- このアプローチは,タンパク質の設計を加速し,リガンド-受容体の相互作用を最適化するための大きな可能性を秘めています.
関連する概念動画
02:13Nuclear Binding Energy
14.8K
The difference between the calculated and experimentally measured masses is known as the mass defect of the atom. In the case of helium-4, the mass defect indicates a “loss” in mass of 4.0331 amu – 4.0026 amu = 0.0305 amu. The loss in mass accompanying the formation of an atom from protons, neutrons, and electrons is due to the conversion of that mass into energy that is evolved as the atom forms. The nuclear binding energy is the energy produced when the atoms’ nucleons are bound...
14.8K
02:04Protein-protein Interfaces
14.8K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.8K
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
580
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
580
03:06From DNA to Protein
22.6K
The flow of genetic information in cells from DNA to mRNA to protein is described by the central dogma, which states that genes specify the sequence of mRNAs, which in turn specify the sequence of amino acids making up all proteins. The decoding of one molecule to another is performed by specific proteins and RNAs. Because the information stored in DNA is so central to cellular function, it makes intuitive sense that the cell would make mRNA copies of this information for protein synthesis...
22.6K
02:26Conservation of Protein Domains Over Different Proteins
14.7K
Protein domains are small structurally independent units that are part of a single amino acid chain. Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
14.7K
02:50Conjugated Proteins
29.1K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
29.1K